<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="41300">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02568722</url>
  </required_header>
  <id_info>
    <org_study_id>STARRT-AKI: Principal Trial</org_study_id>
    <nct_id>NCT02568722</nct_id>
  </id_info>
  <brief_title>Standard vs. Accelerated Initiation of RRT in Acute Kidney Injury (STARRT-AKI: Principal Trial)</brief_title>
  <official_title>STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Michael's Hospital, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Institutes of Health Research (CIHR)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>The George Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Michael's Hospital, Toronto</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this trial are to determine whether, in critically ill patients with
      severe acute kidney injury (AKI), randomization to accelerated initiation of renal
      replacement therapy (RRT), compared to standard initiation, leads to:

        1. Improved survival (primary outcome); and

        2. Recovery of kidney function (principal secondary outcome), defined as independence from
           RRT at 90 days
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute kidney injury (AKI) is a common and devastating complication of critical illness. Once
      AKI is established, treatment is largely supportive and no intervention has been found to
      restore kidney function or improve overall survival. Renal replacement therapy (RRT),
      usually in the form of hemodialysis, is frequently needed to manage patients with severe
      AKI. Such patients have an in-hospital mortality that consistently exceeds 50% with delays
      in RRT initiation implicated as a possible contributor. A recent meta-analysis suggested
      that earlier initiation of RRT may improve survival, but this is based on data derived
      overwhelmingly from observational studies. The investigators recently completed a
      multi-centre randomized controlled pilot trial that confirmed the feasibility of allocating
      patients to two different strategies of RRT initiation. Patient recruitment and follow-up,
      as well as patient safety, were successfully demonstrated during the pilot phase of this
      research program. The optimal timing of RRT initiation is an existing knowledge gap and a
      clear priority for investigation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All-cause mortality.</measure>
    <time_frame>90 days following study randomization.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>RRT dependence</measure>
    <time_frame>90 days following study randomization.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite of death or RRT dependence.</measure>
    <time_frame>90 days following study randomization.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of estimated glomerular filtration rate.</measure>
    <time_frame>90 days following study randomization.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of albuminuria.</measure>
    <time_frame>90 days following study randomization.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse kidney outcomes.</measure>
    <time_frame>90 days following study randomization.</time_frame>
    <description>Defined as death, RRT dependence or sustained reduction in kidney function (defined as eGFR &lt; 75% baseline eGFR).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mechanical ventilation-free days.</measure>
    <time_frame>Measured from randomization through day 28.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vasoactive therapy-free days</measure>
    <time_frame>Measured from randomization through day 28.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU-free days</measure>
    <time_frame>Measured from randomization through day 28.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization-free days</measure>
    <time_frame>Measured from randomization through day 90.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death in ICU</measure>
    <time_frame>Measured in-hospital and at day 28.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EuroQoL EQ-5D-5L.</measure>
    <time_frame>Measured at day 90 and at day 365.</time_frame>
    <description>A measure of health-related quality of life and patient utility.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health care costs.</measure>
    <time_frame>Measured from baseline through day 365.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite of death or RRT dependence.</measure>
    <time_frame>Measured at day 365.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2866</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>Standard RRT initiation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>RRT initiation will be guided by the presence of one or more clinical indications. Even in the absence of one of these indications, RRT may be commenced at the discretion of the treating physician.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Accelerated RRT initiation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A dialysis catheter will be placed and RRT initiated as soon as possible and within 12 hours of the patient meeting the eligibility criteria.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard RRT initiation</intervention_name>
    <description>In the absence of kidney function recovery, the initiation of RRT will be permitted if one of the following develops:
serum potassium ≥ 6.0 mmol/L; pH ≤ 7.20 or serum bicarbonate ≤ 12 mmol/L; evidence of severe respiratory failure, based on a PaO2/FiO2 ≤ 200 and clinical perception of volume overload; and/or persistent AKI &gt; 72 hours following the time of randomization.</description>
    <arm_group_label>Standard RRT initiation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Accelerated RRT initiation</intervention_name>
    <description>A dialysis catheter will be placed and RRT initiated as soon as possible and within 12 hours of eligibility. This 12 hour window includes the time needed to obtain consent.</description>
    <arm_group_label>Accelerated RRT initiation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ≥ 18 years

          2. Admission to an intensive care unit (ICU)

          3. Evidence of kidney dysfunction [serum creatinine ≥100 µmol/L (women) and ≥ 130 µmol/L
             (men)]

          4. Evidence of severe AKI defined by at least 1 of the following 3 criteria:

             i) ≥ 2-fold increase in serum creatinine from a known pre-morbid baseline or during
             the current hospitalization; OR ii) Achievement of a serum creatinine ≥ 354 µmol/L
             with evidence of a minimum increase of 27 µmol/L from pre-morbid baseline or during
             the current hospitalization; OR iii) Urine output &lt; 6.0 mL/kg over the preceding 12
             hours

        Exclusion Criteria:

          1. Serum potassium &gt; 5.5 mmol/L

          2. Serum bicarbonate &lt; 15 mmol/L

          3. Presence of a drug overdose that necessitates initiation of RRT

          4. Lack of commitment to ongoing life support (including RRT)

          5. Any RRT within the previous 2 months (either acute or chronic RRT)

          6. Kidney transplant within the past 365 days

          7. Known pre-hospitalization advanced chronic kidney disease, defined by an estimated
             glomerular filtration rate &lt; 20 mL/min/1.73 m2

          8. Presence or clinical suspicion of renal obstruction, rapidly progressive
             glomerulonephritis, vasculitis, thrombotic microangiopathy or acute interstitial
             nephritis

          9. Clinician(s) caring for patient believe(s) that immediate RRT is mandated

         10. Clinician(s) caring for patient believe(s) that deferral of RRT initiation is
             mandated

               -  at their discretion, clinicians may administer a bolus of intravenous furosemide
                  (ie, &quot;furosemide stress test&quot;) and evaluate the subsequent urine output to help
                  guide decision making regarding the likelihood of AKI progression
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ron Wald, MDCM MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Michael's Hospital, Toronto</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sean M Bagshaw, MD MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alberta</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shristi Bhatia, BSc</last_name>
    <phone>416-864-6060</phone>
    <phone_ext>76210</phone_ext>
    <email>bhatiash@smh.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Judith Hall, MSc</last_name>
    <phone>416-864-6060</phone>
    <phone_ext>7121</phone_ext>
    <email>hallju@smh.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Suzanne Weist</last_name>
      <email>weist.suanne@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Kianoush Kashani</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Princess Alexandra Hospital</name>
      <address>
        <city>Woolloongabba</city>
        <state>Queensland</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Kruger</last_name>
    </contact>
    <contact_backup>
      <email>p.kruger1@uq.edu.au</email>
    </contact_backup>
    <investigator>
      <last_name>Peter Kruger</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Austin Hospital</name>
      <address>
        <city>Heidelberg</city>
        <state>Victoria</state>
        <zip>3084</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Glenn Eastwood, RN PhD</last_name>
      <phone>03 9496 4835</phone>
      <email>Glenn.EASTWOOD@austin.org.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Alfred Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Udy</last_name>
    </contact>
    <contact_backup>
      <email>andrew@udy.com</email>
    </contact_backup>
    <investigator>
      <last_name>Andrew Udy</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nepean Hospital</name>
      <address>
        <city>Kingswood</city>
        <zip>NSW 2747</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rebecca Gresham</last_name>
      <email>Gresham@health.nsw.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>Christina Whitehead</last_name>
      <email>Christina.Whitehead@health.nsw.gov.au</email>
    </contact_backup>
    <investigator>
      <last_name>Louise Cole</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nambour General Hospital</name>
      <address>
        <city>Nambour</city>
        <zip>QLD 4560</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne Buckley</last_name>
      <email>Anne.buckley@health.qld.gov.au</email>
    </contact>
    <investigator>
      <last_name>Victoria Campbell</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Western Health (Footscray Hospital &amp; Sunshine Hospital)</name>
      <address>
        <city>St Albans</city>
        <zip>VIC 3021</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samantha Bates</last_name>
      <email>samantha.bates@wh.org.au</email>
    </contact>
    <investigator>
      <last_name>Dashiell Gantner</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Prince Alfred Hospital</name>
      <address>
        <city>Sydney</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Heidi Buhr</last_name>
      <email>heidi.buhr@sswahs.nsw.gov.au</email>
    </contact>
    <investigator>
      <last_name>David Gattas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Joannidis</last_name>
      <phone>0043-512-504-24180</phone>
      <email>michael.joannidis@i-med.ac.at</email>
    </contact>
    <investigator>
      <last_name>Michael Joannidis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ghent University Hospital</name>
      <address>
        <city>Ghent</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eric Hoste</last_name>
      <email>eric.hoste@ugent.be</email>
    </contact>
    <investigator>
      <last_name>Eric Hoste, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Foothills Hospital</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Terry Stelfox</last_name>
      <email>tstelfox@ucalgary.ca</email>
    </contact>
    <investigator>
      <last_name>Tom Stelfox</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Alberta Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2B7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sean M Bagshaw, MD MSc</last_name>
      <phone>780-407-6755</phone>
      <email>bagshaw@ualberta.ca</email>
    </contact>
    <contact_backup>
      <last_name>Nadia Baig</last_name>
      <phone>780-492-9951</phone>
      <email>Nadia.Baig@albertahealthservices.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Sean M Bagshaw, MD MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Grey Nuns Community Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shelley Duggan</last_name>
      <email>sduggan@sedmneph.ca</email>
    </contact>
    <investigator>
      <last_name>Shelley Duggan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Alexandra Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jim Kutsogiannis</last_name>
      <email>djk3@ualberta.ca</email>
    </contact>
    <investigator>
      <last_name>Jim Kutsogiannis</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Zygun</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Paul's Hospital - Providence Health Care</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Dodek</last_name>
      <email>peter.dodek@ubc.ca</email>
    </contact>
    <investigator>
      <last_name>Peter Dodek</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hamilton General Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Whitlock</last_name>
      <email>Richard.Whitlock@phri.ca</email>
    </contact>
    <investigator>
      <last_name>Richard Whitlock</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Juravinski Hospital</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bram Rochwerg</last_name>
      <email>bram.rochwerg@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Bram Rochwerg</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tim Karachi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Healthcare Hamilton</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Soth</last_name>
      <email>msoth@stjosham.on.ca</email>
    </contact>
    <investigator>
      <last_name>Mark Soth</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kingston General Hospital</name>
      <address>
        <city>Kingston</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Muscedere</last_name>
      <email>muscedej@KGH.KARI.NET</email>
    </contact>
    <investigator>
      <last_name>John Muscedere</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre, University Hospital</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Matthew Weir</last_name>
      <email>Matthew.Weir@lhsc.on.ca</email>
    </contact>
    <investigator>
      <last_name>Matthew Weir</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre, Victoria Hospital</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Matthew Weir</last_name>
      <email>Matthew.Weir@lhsc.on.ca</email>
    </contact>
    <investigator>
      <last_name>Matthew Weir</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lakeridge Health</name>
      <address>
        <city>Oshawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Randy Wax</last_name>
    </contact>
    <investigator>
      <last_name>Randy Wax</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hospital, Civic Campus</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauralyn McIntyre</last_name>
      <email>lmcintyre@ohri.ca</email>
    </contact>
    <contact_backup>
      <last_name>Rebecca Porteous</last_name>
      <phone>(613) 737-8823</phone>
      <email>rporteous@Ottawahospital.on.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Lauralyn McIntyre</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hospital, General Campus</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauralyn McIntyre</last_name>
      <email>lmcintyre@ohri.ca</email>
    </contact>
    <contact_backup>
      <last_name>Rebecca Porteous</last_name>
      <phone>(613) 737-8823</phone>
      <email>rporteous@Ottawahospital.on.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Lauralyn McIntyre</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Health Sciences North</name>
      <address>
        <city>Sudbury</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Kivi</last_name>
      <phone>705.523.7300</phone>
      <phone_ext>1926</phone_ext>
      <email>jekivi@amric.ca</email>
    </contact>
    <investigator>
      <last_name>Navdeep Mehta</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Harmon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Lapinsky</last_name>
      <email>slapinsky@mtsinai.on.ca</email>
    </contact>
    <investigator>
      <last_name>Stephen Lapinsky</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Michael's Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ron Wald, MDCM, MPH</last_name>
      <phone>416-867-3703</phone>
      <email>waldr@smh.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neill Adhikari</last_name>
    </contact>
    <contact_backup>
      <last_name>Nicole Marinoff</last_name>
      <phone>416-480-6100</phone>
      <phone_ext>1719</phone_ext>
      <email>Nicole.Marinoff@sunnybrook.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Neill Adhikari, MDCM, M.Sc.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Toronto General Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Margaret Herridge</last_name>
      <email>margaret.herridge@uhn.ca</email>
    </contact>
    <investigator>
      <last_name>Margaret Herridge</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Toronto Western Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elizabeth Wilcox</last_name>
      <email>elizabeth.wilcox@uhn.on.ca</email>
    </contact>
    <investigator>
      <last_name>Elizabeth Wilcox</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier de l'université de Montréal (Notre Dame)</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-François Cailhier</last_name>
      <email>jf.cailhier@umontreal.ca</email>
    </contact>
    <investigator>
      <last_name>Jean-François Cailhier</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier de l'université de Montréal (St. Luc)</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-François Cailhier</last_name>
      <email>jf.cailhier@umontreal.ca</email>
    </contact>
    <investigator>
      <last_name>Jean-François Cailhier</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHUM - Hôtel Dieu Montreal</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-François Cailhier</last_name>
      <email>jf.cailhier@umontreal.ca</email>
    </contact>
    <investigator>
      <last_name>Jean-François Cailhier</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Maisonneuve-Rosemont</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Philippe Lafrance</last_name>
      <email>jean-philippe.lafrance@umontreal.ca</email>
    </contact>
    <investigator>
      <last_name>Jean-Philippe Lafrance</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>McGill University Health Centre (MUHC)</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sheldon Magder</last_name>
      <email>sheldon.magder@muhc.mcgill.ca</email>
    </contact>
    <investigator>
      <last_name>Sheldon Magder</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hôspitalier universitaire de Sherbrooke (CHUS)</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chantal Langevin</last_name>
      <phone>819-346-1110</phone>
      <phone_ext>26954</phone_ext>
      <email>clangevin.chus@ssss.gouv.qc.ca</email>
    </contact>
    <investigator>
      <last_name>François Lamontagne</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre de sante et de services sociaux de Trois-Rivieres</name>
      <address>
        <city>Trois-Rivières</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Danielle Tapps</last_name>
      <phone>819-697-3333</phone>
      <email>danielle_tapps@ssss.gouv.qc.ca</email>
    </contact>
    <investigator>
      <last_name>Ying Tung Sia</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Regina Qu'Appelle Health Region</name>
      <address>
        <city>Saskatoon</city>
        <state>Saskatchewan</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer StOnge</last_name>
      <email>Jennifer.StOnge@rqhealth.ca</email>
    </contact>
    <investigator>
      <last_name>Bhanu Prasad</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Quebec (CHUQ)</name>
      <address>
        <city>Quebec</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marie-Claude Tremblay</last_name>
      <email>Marie-Claude.Tremblay@crchudequebec.ulaval.ca</email>
    </contact>
    <investigator>
      <last_name>Alexis Turgeon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00290</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sari Sutinen</last_name>
      <phone>+358-50-428 7330</phone>
      <email>sari.sutinen@hus.fi</email>
    </contact>
    <investigator>
      <last_name>Ville Pettila</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Suvi Vaara</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna-Maija Korhonen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Vincent's University Hospital</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kathy Brickell</last_name>
      <phone>+353 1 7165826</phone>
      <email>kathy.brickell@ucd.ie</email>
    </contact>
    <investigator>
      <last_name>Alistair Nichol</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Auckland City Hospital</name>
      <address>
        <city>Grafton</city>
        <state>Auckland</state>
        <zip>1148</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shay McGuinness</last_name>
    </contact>
    <contact_backup>
      <email>shaymc@adhb.govt.nz</email>
    </contact_backup>
    <investigator>
      <last_name>Shay McGuinness</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wellington Hospital</name>
      <address>
        <city>Wellington</city>
        <zip>6021</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Hunt</last_name>
      <email>Anna.Hunt@ccdhb.org.na</email>
    </contact>
    <investigator>
      <last_name>Paul Young</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guy's and St. Thomas Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marlies Ostermann</last_name>
      <email>marlies.ostermann@gstt.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Marlies Ostermann</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Finland</country>
    <country>Ireland</country>
    <country>New Zealand</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <lastchanged_date>June 27, 2016</lastchanged_date>
  <firstreceived_date>September 29, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Renal replacement therapy</keyword>
  <keyword>Acute kidney injury</keyword>
  <keyword>Dialysis</keyword>
  <keyword>Hemodialysis</keyword>
  <keyword>Critical illness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
